Cargando…

Impacts of MicroRNA-483 on Human Diseases

MicroRNAs (miRNAs) are short non-coding RNA molecules that regulate gene expression by targeting specific messenger RNAs (mRNAs) in distinct cell types. This review provides a com-prehensive overview of the current understanding regarding the involvement of miR-483-5p and miR-483-3p in various physi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matson, Katy, Macleod, Aaron, Mehta, Nirali, Sempek, Ellie, Tang, Xiaoqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366739/ https://www.ncbi.nlm.nih.gov/pubmed/37489457 http://dx.doi.org/10.3390/ncrna9040037

Ejemplares similares

MicroRNA‐483 amelioration of experimental pulmonary hypertension
por: Zhang, Jin, et al.
Publicado: (2020)

Endothelial MicroRNA-483-3p Is Hypertension-Protective
por: Shang, Fenqing, et al.
Publicado: (2022)

microRNA-483 ameliorates hypercholesterolemia by inhibiting PCSK9 production
por: Dong, Jianjie, et al.
Publicado: (2020)

Transgenic overexpression of microRNA-30d in pancreatic beta-cells progressively regulates beta-cell function and identity
por: Mao, Yiping, et al.
Publicado: (2022)

The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases
por: Weng, Yu-Ting, et al.
Publicado: (2023)

Elevated serum microRNA 483-5p levels may predict patients at risk of post-operative atrial fibrillation
por: Harling, Leanne, et al.
Publicado: (2017)

Predicting Value of ALCAM as a Target Gene of microRNA-483-5p in Patients with Early Recurrence in Hepatocellular Carcinoma
por: Lu, Xin-Yuan, et al.
Publicado: (2018)

MicroRNA-483-5p Predicts Poor Prognosis and Promotes Cancer Metastasis by Targeting EGR3 in Nasopharyngeal Carcinoma
por: Li, Xi-Zhao, et al.
Publicado: (2021)

LINC00908 negatively regulates microRNA-483-5p to increase TSPYL5 expression and inhibit the development of prostate cancer
por: Fan, Li, et al.
Publicado: (2020)

Upregulated MicroRNA-483-3p is an Early Event in Pancreatic Ductal Adenocarcinoma (PDAC) and as a Powerful Liquid Biopsy Biomarker in PDAC
por: Shao, Huilin, et al.
Publicado: (2021)

MicroRNA-483-5p Inhibits Hepatocellular Carcinoma Cell Proliferation, Cell Steatosis, and Fibrosis by Targeting PPARα and TIMP2
por: Niture, Suryakant, et al.
Publicado: (2023)

MicroRNA in Human Glioma
por: Li, Mengfeng, et al.
Publicado: (2013)

Plasma microRNA profiling in nasopharyngeal carcinoma patients reveals miR-548q and miR-483-5p as potential biomarkers
por: Zheng, Xiao-Hui, et al.
Publicado: (2014)

Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases
por: Zhang, Juan, et al.
Publicado: (2022)

MicroRNA Processing and Human Cancer
por: Ohtsuka, Masahisa, et al.
Publicado: (2015)

MicroRNA and Human Bone Health
por: Cheng, Vincent Ka‐Fai, et al.
Publicado: (2018)

Genetic variants in microRNA genes: impact on microRNA expression, function, and disease
por: Cammaerts, Sophia, et al.
Publicado: (2015)

MicroRNA and Cardiovascular Diseases
por: Çakmak, Hüseyin Altuğ, et al.
Publicado: (2020)

Role of MicroRNA-502-3p in Human Diseases
por: Devara, Davin, et al.
Publicado: (2023)

The MicroRNA-21 in Autoimmune Diseases
por: Wang, Shaowen, et al.
Publicado: (2016)

MicroRNA in United Airway Diseases
por: Liu, Zheng, et al.
Publicado: (2016)

MicroRNA-214 in Health and Disease
por: Amin, Meer M. J., et al.
Publicado: (2021)

Pre-microRNA and Mature microRNA in Human Mitochondria
por: Barrey, Eric, et al.
Publicado: (2011)

Principles of microRNA involvement in human cancers
por: Ling, Hui, et al.
Publicado: (2011)

MicroRNA Regulation of Human Herpesvirus Latency
por: Chen, Siyu, et al.
Publicado: (2022)

microRNA: The Impact on Cancer Stemness and Therapeutic Resistance
por: Jiao, Xueqiao, et al.
Publicado: (2019)

SNPs in microRNA target sites and their potential role in human disease
por: Moszyńska, Adrianna, et al.
Publicado: (2017)

microRNA biomarkers in cystic diseases
por: Woo, Yu Mi, et al.
Publicado: (2013)

MicroRNA 483‐3p overexpression unleashes invasive growth of metastatic colorectal cancer via NDRG1 downregulation and ensuing activation of the ERBB3/AKT axis
por: Candiello, Ermes, et al.
Publicado: (2023)

MicroRNA-503 and the Extended MicroRNA-16 Family in Angiogenesis
por: Caporali, Andrea, et al.
Publicado: (2011)

Role of microRNA-129 in cancer and non-cancerous diseases (Review)
por: Deng, Bingpeng, et al.
Publicado: (2021)

An Analysis of Human MicroRNA and Disease Associations
por: Lu, Ming, et al.
Publicado: (2008)

MicroRNAs in Common Human Diseases
por: Li, Yu, et al.
Publicado: (2012)

Influence of microRNA on the Maintenance of Human Iron Metabolism
por: Davis, McKale, et al.
Publicado: (2013)

Regulation of microRNA-497 expression in human cancer
por: Luo, Guanshui, et al.
Publicado: (2021)

Long noncoding RNA NR2F1-AS1 enhances the malignant properties of osteosarcoma by increasing forkhead box A1 expression via sponging of microRNA-483-3p
por: Li, Shenglong, et al.
Publicado: (2019)

Exam ref 70-483: programming in C♯
por: Miles, Rob
Publicado: (2019)

Exam ref 70-483: programming in C#
por: Kort, Wouter de
Publicado: (2013)

483. OPAT Delivery during COVID-19
por: Swartwood, Michael J, et al.
Publicado: (2020)

MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial–mesenchymal transition in anaplastic thyroid cancer cells
por: Zhang, Xiaoping, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_54vo6h6i1kd2btbat4kitmghha